News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.


Antibody Guarantee

CST Antibody Performance Guarantee



Find answers on our FAQs page.


PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools


Western blot analysis of extracts from HT-1080 cells, serum-starved overnight and untreated (-) or treated with Human Transforming Growth Factor β1 (hTGF-β1) #8915 (10 ng/ml, 30 min; +) either with or without SB431542 pre-treatment (1 hr, indicated concentrations), using Phospho-Smad2 (Ser465/467)/Smad3 (Ser423/425) (D27F4) Rabbit mAb #8828 (upper) and Smad2/3 (D7G7) XP® Rabbit mAb #8685 (lower).

Learn more about how we get our images

Chemical structure of SB431542.

Learn more about how we get our images

Product Usage Information

SB431542 is supplied as a lyophilized powder. For a 10 mM stock, reconstitute the 1 mg in 260.15 μl DMSO. Working concentrations and length of treatment can vary depending on the desired effect, but it is typically used as a pretreatment at 1-10 μM for 0.5-2 hr prior to treating with a stimulator. It can also be used alone, with varying treatment times lasting up to 24 hr.

Storage: Store lyophilized or in solution at -20ºC, desiccated. Protect from light. In lyophilized form, the chemical is stable for 24 months. Once in solution, use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight:

384.4 g/mol



Molecular Formula:


SB431542 is a potent and selective ATP-competitive inhibitor of the transforming growth factor β1 (TGF-β1) activin receptor-like kinases (ALK) -4, -5, and -7 (1-3). Research studies using cell-free kinase assays show that SB431542 inhibits ALK4 and ALK5 with IC50 values of 140 nM and 94 nM, respectively, and ALK7 with slightly less potency (2,3). The SB431542 inhibitor displays a 100-fold greater selectivity for ALK5 than 25 other kinases, including p38 MAPK and JNK1 (3). SB431542 inhibits Smad2 signaling induced by TGF-β and activin, but has no effect on BMP-induced Smad1 activation mediated by ALK -2, -3, and -6 (3,4). Additional studies show that SB431542 enhances the proliferation and integrity of ESC-derived endothelial cells (5).

1.  Callahan, J.F. et al. (2002) J Med Chem 45, 999-1001.

2.  Laping, N.J. et al. (2002) Mol Pharmacol 62, 58-64.

3.  Inman, G.J. et al. (2002) Mol Pharmacol 62, 65-74.

4.  Daly, A.C. et al. (2008) Mol Cell Biol 28, 6889-902.

5.  Watabe, T. et al. (2003) J Cell Biol 163, 1303-11.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.